{"id":"doi:10.1056/nejmoa2307563","kind":"article","title":"Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes","authors":["Abraham Michael Lincoff","Kirstine Brown‐Frandsen","Helen Martina Colhoun","John Eric Deanfield","Scott S. Emerson","Sille Esbjerg","Søren Hardt‐Lindberg","G. Kees Hovingh","Steven E. Kahn","Robert F. Kushner","Ildiko Lingvay","Tuğçe Kalaycı Oral","Marie Mide Michelsen","Jorge Plutzky","Christoffer Wenzel Tornøe","Donna H. Ryan"],"author_count":16,"year":2023,"published":"2023-11-11","venue":"New England Journal of Medicine","cited_by":3220,"doi":"10.1056/nejmoa2307563","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa2307563","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa2307563","updated":null,"pmid":"37952131","pmcid":null,"openalex_id":"W4388592674","pdf_url":"https://discovery.ucl.ac.uk/10184940/1/nejmoa2307563.pdf","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Diabetes Treatment and Management"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}